Trials Sponsors Conditions Drugs Pricing

Conditions

Healthy

Keywords

AntimicrobialAntisepsisTopical antisepsis

Outcome Measures

Primary Outcomes (1)

3.0 log10 reduction in CFU/cm2 on inguinal sites, and 2.0 log10 reduction in CFU/cm2 on abdominal sites
10 minutes and 6 hours after application of test solutions

Secondary Outcomes (1)

Impact of blotting versus not blotting
Blotting and not blotting after 2 minute application with CHG and 5 minute application of iodophor

Study Arms (2)

1

EXPERIMENTAL

Chlorhexidine gluconate 2%

Drug: Chlorhexidine gluconate

2

ACTIVE COMPARATOR

Povidone iodine scrub and paint

Drug: Povidone iodine

Interventions

Chlorhexidine gluconateDrug

Chlorhexidine gluconate (2% w/v) in an aqueous base. Administered topically.

Also known as: ChloraPrep AQ

Povidone iodineDrug

Povidone iodine scrub and paint. Administer topically.

Also known as: Betadine

Eligibility Criteria

Age18 Years - 90 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Free of dermatoses, cuts, lesions, or other skin disorders around test sites
must not have received topical or systemic antimicrobials, antibiotics, or steroids for 7 days prior to testing and agree to abstain from these materials until completion of the study

Sponsors & Collaborators

C. R. Bard
Industrylead

Study Sites (1)

BioScience Laboratories

Bozeman, Montana, 59715, United States

MeSH Terms

Interventions

chlorhexidine gluconatePovidone-Iodine

Intervention Hierarchy (Ancestors)

IodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-Ring

Study Officials

Daryl S Paulsen, PhD
President and CEO
PRINCIPAL INVESTIGATOR

Enrollment

122 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 3
Allocation: RANDOMIZED
Masking: NONE
Purpose: OTHER
Intervention Model: PARALLEL
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 4, 2008

First Posted

June 6, 2008

Study Start

October 2007

Date type not reported

This date has not been verified as actual or estimated.

Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 Antiseptics

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

1

2

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

1

2

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations